Q over Q and Y over Y increases..
Check this out, from the most recent quarterly report. Very nice increases from this little company!
Q ending 8/2012
Net Sales 1,951,608
Net Op Profit 541,993
Net Income 350,644
Net inc/share 0.01
Q ending 8/2013
Net Sales 1,362,217
Net Op Profit 178,887
Net Income 118,073
Net inc/share 0.00
Q ending 5/2012
Net Sales 1,744,165
Net Op Profit 146,121
Net Income 90,339
Net inc/share 0.00
“Net Sales increase was due in part to a substantial increase in sales of RMS HIgH-Flo Subcutaneous Safety Needle Sets, quarter over quarter."
"The company’s sales of its FREEDOM60® and RMS HIgH-Flo™ needle set product lines improved in both domestic and international markets.
"Regarding the Freedom60: In order to receive more favorable Medicare reimbursement for our FREEDOM60® Syringe Infusion System, we had submitted a formal request for a HCPCS coding verification with the Statistical Analysis Durable Medical Equipment Regional Carrier (SADMERC). It was the determination that the Medicare HCPCS code(s) to bill the four Durable Medical Regional Carries (DMERCs) should be: “E0779 Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater.” The new code significantly increases the reimbursement for the FREEDOM60® for billable syringe pump application approved by Medicare. Current approved uses under Medicare include among others, subcutaneous immune globulin, antivirals, antifungals, and chemotherapeutics. In June 2007, Medicare issued a letter of clarification stating in part:
“The FREEDOM60® Syringe Infusion Pump is the only allowable pump to be billed with the Subcutaneous Immune Globulin (SCIg). The code for this pump for dates of service 1/1/00 - 5/16/07 is E0780. For dates of service on or after 5/17/07, the correct code is E0779 per SADMERC. The items being billed must be supported by corresponding documentation. All other pumps or modifiers will result in a denial.”
